FIND scouts for innovative, new diagnostic solutions for poverty-related diseases. In particular, we seek diagnostic solutions that meet specific, priority needs described by target product profiles and platform solutions that can be used across several diseases. Researchers and developers are invited to submit technology, biomarker and/or product proposals via our submission webform.
Why work with FIND?
There are many challenges in developing diagnostic products to meet the needs of low and middle income countries. Developers need to understand the precise user requirements and expectations from public health authorities, like the World Health Organization. Research and development processes are slowed down because of the difficulties to access well characterized samples and study sites. Manufacturers may not be aware of the approval processes that are required to get products into the public health markets in developing countries and might be unfamiliar with the needs of health care delivery systems in low-resource settings.
FIND helps developers and manufacturers overcome these challenges by reducing the hurdles on the road from product development to market access and impact. This can be achieved, for example, through access to our sample and strain banks, support in the conceptualization of appropriate clinical and regulatory studies, and access to our network of clinical study sites. In addition, we have established partnerships between developers, manufacturers and distribution networks, and can also be a partner in grant applications.
Submission process outline
Submission & review process details
We have established a comprehensive process for the assessment of promising proposals. Any party interested in submitting a suitable technology, biomarker or product proposal should use our submission webform.
In case none of the submission templates in the webform are suitable and yet you believe that your proposal addresses a major unfulfilled diagnostic need for a developing country health system, please go to Disease Area in the webform and choose “Other”.
We strive to provide timely and qualified feed-back for every proposal. The submitter will receive an acknowledgement of receipt within a few days after submission. At this point, the proposal enters a two-stage assessment process. An Initial Analysis will determine whether a proposal has the potential to address the specific needs outlined in the submission forms. These assessments are a completed by the technology scouting team and a the specified disease team, with the oversight and approval of the head of the disease programme.
A more detailed reply will be sent not later than eight weeks from the time of submission. After a successful Initial Analysis, a more detailed technical review, or In-depth Analysis, of the proposal will take place, which typically involves direct interactions with the submitter and will address the factors needed for success. Depending on the complexity, the completion of this In-depth Analysis will occur within two to three months from the time of submission. Again, the submitter will be informed about the conclusions shortly after the final decision has taken place.
On occasion, promising proposals may not entirely fulfil the requirements for a successful recommendation during either the Initial Analysis or the In-depth Analysis phase. This could be an opportunity to leverage FIND-specific support capabilities (see WHY work with FIND), which can significantly enhance the chances of a successful re-submission or continuation of the assessment process. After completion of the In-depth Analysis and approval by the FIND management committee, both parties may initiate discussions on an effective introduction of a diagnostic solution for developing country markets.
If you have any questions, please don’t hesitate to contact the FIND Technology Team at email@example.com.